ReferIndia News Supriya Lifescience targets Rs 1,600-cr revenue in three years on capacity expansion

ReferIndia News

Dr. Aditya Manke

Dr. Aditya Manke — Expert Robotic & Laparoscopic Cancer Surgeon. Precise care, faster recovery.

Contact Now
News Image

Supriya Lifescience targets Rs 1,600-cr revenue in three years on capacity expansion

Published on: Dec. 16, 2025, 5:55 p.m. | Source: The Economic Times

Supriya Lifescience plans to reach Rs 1,600 crore revenue in three years. New facilities in Lote MIDC and Ambernath will drive this growth. The company focuses on niche, complex APIs, moving away from mass-volume products. New product launches and contract manufacturing tie-ups are also planned. Supriya Lifescience is debt-free, funding expansion through internal accruals.

Checkout more news
Ad Banner

Best Surgical Oncologist in Mumbai

Advanced Robotic & Laparoscopic Cancer Surgery by Dr. Aditya Manke — expert care with faster, safer recovery. Specialist in GI, HPB, and complex cancer surgeries, delivering precision treatment with c

Know more
ReferIndia News contact